ITCC-051 COMIBETINIB
A Phase I/II, Multicenter, Open-Label, dose‑escalation Study of the Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Patients with Previously treated Solid Tumors
Promotor Name : HOFFMAN LA ROCHE
Investigator Name : B. GEOERGER
Trial registered on clinicaltrial.gov: NCT02639546